43 related articles for article (PubMed ID: 3280507)
1. Lymphocyte targeting with 111In-labelled monoclonal antibodies.
Loutfi I; Batchelor JR; Lavender JP; Epenetos AA
Int J Cancer Suppl; 1988; 2():45-9. PubMed ID: 3280507
[TBL] [Abstract][Full Text] [Related]
2. New monoclonal antibodies SN3, SN3a, and SN3b directed to sialic acid of glycoprotein on human non-T leukemia cells.
Fukukawa T; Matsuzaki H; Haruta Y; Hara H; Seon BK
Exp Hematol; 1986 Oct; 14(9):850-5. PubMed ID: 3489635
[TBL] [Abstract][Full Text] [Related]
3. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
Epstein AL; Marder RJ; Winter JN; Fox RI
J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
Wong JY; Thomas GE; Yamauchi D; Williams LE; Odom-Maryon TL; Liu A; Esteban JM; Neumaier M; Dresse S; Wu AM; Primus FJ; Shively JE; Raubitschek AA
J Nucl Med; 1997 Dec; 38(12):1951-9. PubMed ID: 9430476
[TBL] [Abstract][Full Text] [Related]
5. Use of the monoclonal antibody WR17, identifying the CD37 gp40-45 Kd antigen complex, in the diagnosis of B-lymphoid malignancy.
Moore K; Cooper SA; Jones DB
J Pathol; 1987 May; 152(1):13-21. PubMed ID: 3305845
[TBL] [Abstract][Full Text] [Related]
6. Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouse.
Goodwin DA; Meares CF; McCall MJ; Haseman MK; McTigue M; Diamanti CI; Chaovapong W
J Nucl Med; 1985 May; 26(5):493-502. PubMed ID: 3921673
[TBL] [Abstract][Full Text] [Related]
7. Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential.
Epstein AL; Marder RJ; Winter JN; Stathopoulos E; Chen FM; Parker JW; Taylor CR
Cancer Res; 1987 Feb; 47(3):830-40. PubMed ID: 3542194
[TBL] [Abstract][Full Text] [Related]
8. Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. IV. A monoclonal antibody reacting specifically with a subpopulation of human B lymphocytes.
Brooks DA; Beckman IG; Bradley J; McNamara PJ; Thomas ME; Zola H
J Immunol; 1981 Apr; 126(4):1373-7. PubMed ID: 6970772
[TBL] [Abstract][Full Text] [Related]
9. Targeting of lymphocytes with 111In-labelled monoclonal antibodies.
Loutfi I; Batchelor JR; Chisholm PM; Epenetos AA; Lavender JP
Nucl Med Commun; 1988 Oct; 9(10):787-96. PubMed ID: 3211438
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical investigation of the cross-reactivity of selected cell markers from various species for characterization of lymphatic tissues in the harbour porpoise (Phocoena phocoena).
Beineke A; Siebert U; Wünschmann A; Stott JL; Prengel I; Kremmer E; Baumgärtner W
J Comp Pathol; 2001 Nov; 125(4):311-7. PubMed ID: 11798248
[TBL] [Abstract][Full Text] [Related]
11. In vivo targeting of dead tumor cells in a murine tumor model using a monoclonal antibody specific for the La autoantigen.
Al-Ejeh F; Darby JM; Pensa K; Diener KR; Hayball JD; Brown MP
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5519s-5527s. PubMed ID: 17875784
[TBL] [Abstract][Full Text] [Related]
12. Production and characterization of monoclonal antibodies to rabbit lymphocyte subpopulations. I. Tissue immunofluorescence and flow cytometric analysis.
Loar LD; Dennison D; Sell S
J Immunol; 1986 Nov; 137(9):2784-90. PubMed ID: 3531340
[TBL] [Abstract][Full Text] [Related]
13. A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16.
Weiner LM; Holmes M; Adams GP; LaCreta F; Watts P; Garcia de Palazzo I
Cancer Res; 1993 Jan; 53(1):94-100. PubMed ID: 8093231
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
[TBL] [Abstract][Full Text] [Related]
15. Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin.
Kernan NA; Knowles RW; Burns MJ; Broxmeyer HE; Lu L; Lee HM; Kawahata RT; Scannon PJ; Dupont B
J Immunol; 1984 Jul; 133(1):137-46. PubMed ID: 6609971
[TBL] [Abstract][Full Text] [Related]
16. Anti-T cell monoclonal antibodies in vivo. I. Inhibition of delayed hypersensitivity but not cutaneous basophil hypersensitivity reactions.
Sobel RA; Hanzakos JL; Blanchette BW; Williams AM; Dellapelle P; Colvin RB
J Immunol; 1987 Apr; 138(8):2500-6. PubMed ID: 3494071
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes.
Chuntharapai A; Lee J; Hébert CA; Kim KJ
J Immunol; 1994 Dec; 153(12):5682-8. PubMed ID: 7527448
[TBL] [Abstract][Full Text] [Related]
18. Effects of radiolabeling monoclonal antibodies with a residualizing iodine radiolabel on the accretion of radioisotope in tumors.
Stein R; Goldenberg DM; Thorpe SR; Basu A; Mattes MJ
Cancer Res; 1995 Jul; 55(14):3132-9. PubMed ID: 7606734
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of tumor antigens and clinical applications of monoclonal antibody (A 2 B 5) for neuroblastoma].
Etoh T
Gan No Rinsho; 1985 Mar; 31(3):299-302. PubMed ID: 3889400
[TBL] [Abstract][Full Text] [Related]
20. Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties.
Carnahan J; Wang P; Kendall R; Chen C; Hu S; Boone T; Juan T; Talvenheimo J; Montestruque S; Sun J; Elliott G; Thomas J; Ferbas J; Kern B; Briddell R; Leonard JP; Cesano A
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3982S-90S. PubMed ID: 14506197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
